| DB ID | MyCo_1066 |
| Title | Clinical significance of (1-->3)-beta-d-glucan in a patient with invasive sino-orbital aspergillosis |
| Year | 2008 |
| PMID | 18650040 |
| Fungal Diseases involved | Invasive sino-orbital aspergillosis |
| Associated Medical Condition | None |
| Genus | Aspergillus |
| Species | spp. |
| Organism | Aspergillus spp. |
| Ethical Statement | None |
| Site of Infection | None |
| Opportunistic invasive | Invasive |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | BDG |
| Biomarker Full Name | 1-3-beta-D-Glucan |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Japan |
| Cohort | A 63-year-old Japanese woman suffered from invasive sino-orbital aspergillosis, was included in the study. |
| Cohort No. | 1 |
| Age Group | 63 |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Assay |
| Analysis Method | BDG assay |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | BDG Assay |
| Up Regulation Down Regulation | Decrease |
| Sequence Data | None |
| External Link | None |
